Use of the VITEK 2 System for Rapid Identification of Clinical Isolates of Staphylococci from Bloodstream Infections
- 1 September 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (9) , 4259-4263
- https://doi.org/10.1128/jcm.41.9.4259-4263.2003
Abstract
Staphylococci are an increasing cause of bloodstream infections. Rapid reliable identification of these organisms is essential for accurate diagnosis and prompt effective treatment. We evaluated the ability of the VITEK 2 system (bioMérieux, Inc, Hazelwood, Mo.) to identify these organisms rapidly and accurately. A total of 405 clinically relevant nonduplicate staphylococcal isolates ( Staphylococcus aureus , n = 130; coagulase-negative staphylococci, n = 275) collected from blood cultures were tested. VITEK 2 results were considered correct when they were identical to those furnished by the comparison method based on the ID 32 STAPH system (bioMérieux, Marcy l'Etoile, France) plus supplementary manual testing. When discrepancies occurred, isolate identity was verified by molecular typing. The VITEK 2 correctly identified 387 (95.6%) isolates at the species level: 379 (including all but one [99.2%] of 130 S. aureus isolates and 249 of 275 [90.5%] coagulase-negative isolates) were identified by the automated reading; for the other eight, supplemental tests suggested by the manufacturer had to be used. Only one strain (0.2%) was misidentified ( Staphylococcus hominis as Staphylococcus epidermidis ), and four (1%), all S. epidermidis , were not identified. For the remaining 13 strains (including 10 S. hominis ), the VITEK 2 system was unable to discriminate among two species, and no supplemental tests were suggested for conclusive identification. Over 90% of results were obtained within 4 h. These results suggest that the VITEK 2 system can provide rapid, accurate, and reliable species-level identification of staphylococci responsible for bloodstream infections, although there is room for improvement in the identification of certain coagulase-negative species, especially S. hominis .Keywords
This publication has 19 references indexed in Scilit:
- Two-Center Collaborative Evaluation of the Performance of the BD Phoenix Automated Microbiology System for Identification and Antimicrobial Susceptibility Testing of Enterococcus spp. and Staphylococcus sppJournal of Clinical Microbiology, 2003
- Evaluation of VITEK 2 Rapid Identification and Susceptibility Testing System against Gram-Negative Clinical IsolatesJournal of Clinical Microbiology, 2001
- Predominant staphylococci in the intensive care unit of a paediatric hospitalJournal of Hospital Infection, 2000
- Determining the Significance of Coagulase-Negative Staphylococci Isolated From Blood Cultures at a Community Hospital A Role for Species and Strain IdentificationInfection Control & Hospital Epidemiology, 2000
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Staphylococcus hominis subsp. novobiosepticus subsp. nov., a novel trehalose- and N-acetyl-D-glucosamine-negative, novobiocin- and multiple-antibiotic-resistant subspecies isolated from human blood culturesInternational Journal of Systematic and Evolutionary Microbiology, 1998
- An inexpensive and reliable method for routine identification of staphylococcal speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus speciesDiagnostic Microbiology and Infectious Disease, 1994
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988